Anne-Marie Duliege
2018
In 2018, Anne-Marie Duliege earned a total compensation of $1.7M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals, a 58% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $368,775 |
|---|---|
| Option Awards | $863,124 |
| Salary | $463,500 |
| Other | $3,354 |
| Total | $1,698,753 |
Duliege received $863.1K in option awards, accounting for 51% of the total pay in 2018.
Duliege also received $368.8K in non-equity incentive plan, $463.5K in salary and $3.4K in other compensation.
Rankings
In 2018, Anne-Marie Duliege's compensation ranked 6,557th out of 14,244 executives tracked by ExecPay. In other words, Duliege earned more than 54.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,557 out of 14,244 | 54th |
Division Manufacturing | 2,510 out of 5,759 | 56th |
Major group Chemicals And Allied Products | 936 out of 2,122 | 56th |
Industry group Drugs | 784 out of 1,811 | 57th |
Industry Pharmaceutical Preparations | 611 out of 1,385 | 56th |
Source: SEC filing on April 9, 2019.
Duliege's colleagues
We found five more compensation records of executives who worked with Anne-Marie Duliege at Rigel Pharmaceuticals in 2018.
2018
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2018
Dolly Vance
Rigel Pharmaceuticals
General Counsel
2018
Eldon Mayer
Rigel Pharmaceuticals
Executive Vice President, Chief Commercial Officer
2018
Esteban Masuda
Rigel Pharmaceuticals
Executive Vice President, Research
2018
Dean Schorno
Rigel Pharmaceuticals